Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-800-2 | CAS number: 126-73-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Principles of method if other than guideline:
- Tributyl phosphate was tested in the chromosome aberration assay using Chinese hamster ovary cells. The assay was conducted both in the absence and presence of an aroclor-induced S-9 activation system at dose levels of 0.013, 0.025, 0.05, 0.1 and 0.15 µl/ml for the non-activated study and 0.01, 0.019, 0.038, 0.075 and 0.15 µl/ml for the S-9 activated study. Metaphase cells were collected at 12 hours after treatment for microscopic evaluation.
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Tributyl phosphate
- EC Number:
- 204-800-2
- EC Name:
- Tributyl phosphate
- Cas Number:
- 126-73-8
- Molecular formula:
- C12H27O4P
- IUPAC Name:
- tributyl phosphate
- Details on test material:
- purity: 99% or greater
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- CHO-K1
- Cytokinesis block (if used):
- yes, colcemid 10µg/mL
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9 mix
9000 x g supernatant of an Aroclor 1254 induced male Sprague Dawley rat liver homogenate - Test concentrations with justification for top dose:
- Test concentrations were selected on the basis of a toxicity test. Metaphase preparations were prepared and stained for sister chromatid differentiation using a modified fluorescence plus Giemsa technique (Perry and Wolff, 1974). Slides were evaluated for the percentage of first, second and third-division metaphase cells for estimation of the test article effect on cell cydle kinetics. The mitotic index was determined for each treatment condition as the percentage of mitogic cells in a population of 500 cells scored. CHO cells were exposed to solvent alone and to nine concentrations of test article ranging from 0.0005 µL/mL to 5 µl/mL in the absence and presence of S9 mix for 6 hours
Based on the findings of the toxicity test, dose levels of
0.013, 0.025, 0.05, 0.1 and 0.15 µl/ml for the non-activated study and
0.01, 0.019, 0.038, 0.075 and 0.15 µl/ml for the S-9 activated study
were selected for the main experiments.
Due to a slight delay observed in cell cycle kinetics, the harvest time was set at 12 hours. - Vehicle / solvent:
- DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- other: Triethylenemelamine (TEM), 0.5 µg/mL
- Evaluation criteria:
- The toxic effects of treatment are based upon mitotic inhibition relative to the solvent-treated control and are presented for the toxicity and aberration study. The number and types of aberrations found are presented for each treatment group. The percentage of structurally damaged cells (percent aberrant cells) in the total population of cells examined was calculated for each group. The frequency of structural aberrations per cell (mean aberrations per cell) was also calculated and reported for each group. Chromatid and iso-chromatid gaps are presented in the data cut are not included in the total percentage of cells with one or more aberrations or in the frequency of structural aberrations per cell.
All conclusions were based on sound scientific basis; however, as a guide to interpretation of the data, the test article was considered to induce a positive response when the percentages of cells with aberrations are increased in a dose responsive
manner with one or more concentrations being statistically elevated relative to the solvent control group (p<0.05). A significant increase at the high dose only with no dose response was considered suspect. A significant increase at one dose level other than the high dose with no dose response was considered equivocal. - Statistics:
- Statistical analysis of the percent aberrant cells was performed using the Fisher's exact test. Fisher's test was used to compare pairwise the percent aberrant cells of each treatment group with that of the solvent control. In the event of a positive Fisher's test at any test article dose level, the Cochran-Armitage test was used to measure dose-responsiveness.
Results and discussion
Test results
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
The activity of Tributyl Phosphate in the induction of chromosome aberrations in CHO cells when treated in the absence of an exogenous source of metabolic activation is summarized by group in Table 5 (see Attachment). The test article was soluble in solvent and treatment medium at all concentrations tested. At the time of harvest, microscopic examination of the cell monolayer indicated slight toxicity at dose level 0.05 ul/ml and moderate to extreme toxicity at dose levels 0.1 and 0.15 ul/ml. No metaphase cells were located tor
analysis at test concentration 0.15 ul/ml. The mitotic index was markedly reduced relative to the solvent control at dose level 0.1 ul/ml. Due to excessive toxicity at test concentration 0.1 ul/ml, only 54 metaphase cells were located tor the analysis of chromosome aberrations. The percentage of cells with structural aberrations in the test article-treated groups was not significantly increased above that of the solvent control (p>0.05, Fisher’s exact test). The percentage of damaged cells in the TEM group was 28% (p<0.01, Fisher’s exact test).
The activity of Tributyl Phosphate in the induction of chromosome aberrations in CHO cells when treated in the presence of an S-9 reaction mixture is summarized by group in Table 5. The test article was soluble in solvent and treatment medium at all concentrations tested. At the time of harvest, dose levels 0.075 and 0.15 ul/ml were observed to be slightly toxic and toxic, respectively, based upon microscopic examination of the cell monolayer. No metaphase cells were located for analysis at test concentration 0.15 µL/mL. The percentage of cells with structural aberrations in the test article-treated groups was not statistically increased above that of the solvent control (p>0.05, Fisher's exact test). The percentage of damaged cells in the CP group was 13% (p<0.01, Fisher's exact test).
The four highest test concentrations with analyzable metaphase cells were evaluated for chromosome aberrations. No increase in chromosome aberrations was observed in either the non-activated or S-9 activated test system. Tributyl phosphate was concluded to be negative in the CHO cytogenetics assay.
Applicant's summary and conclusion
- Executive summary:
Tributyl phosphate was tested in the chromosome aberration assay using Chinese hamster ovary cells. The assay was conducted both in the absence and presence of an Aroclor-induced S-9 activation system at dose levels of 0.013, 0.025, 0.05, 0.1 and 0.15 µl/ml for the non-activated study and 0.01, 0.019, 0.038, 0.075 and 0.15 µl/ml for the S-9 activated study. Metaphase cells were collected at 12 hours after treatment for microscopic evaluation.
Under the conditions of the assay described in this report, tributyl phosphate was concluded to be negative in the CHO cytogenetics assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.